Paris - Delayed Quote • EUR
EssilorLuxottica Société anonyme (EL.PA)
As of 12:55 PM GMT+2. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 17 | 17 |
| Avg. Estimate | 0 | 0 | 7.07 | 7.93 |
| Low Estimate | 0 | 0 | 6.76 | 7.5 |
| High Estimate | 0 | 0 | 7.24 | 8.2 |
| Year Ago EPS | -- | -- | 6.54 | 7.07 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 19 | 18 |
| Avg. Estimate | -- | -- | 26.68B | 28.23B |
| Low Estimate | -- | -- | 26.45B | 27.88B |
| High Estimate | -- | -- | 26.98B | 28.68B |
| Year Ago Sales | -- | -- | 25.39B | 26.68B |
| Sales Growth (year/est) | -- | -- | 5.00% | 5.80% |
Earnings History
| CURRENCY IN USD | ||||
|---|---|---|---|---|
| EPS Est. | -- | -- | -- | -- |
| EPS Actual | -- | -- | -- | -- |
| Difference | -- | -- | -- | -- |
| Surprise % | -- | -- | -- | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 7.07 | 7.93 |
| 7 Days Ago | 0 | 0 | 7.07 | 7.92 |
| 30 Days Ago | 0 | 0 | 7.08 | 7.95 |
| 60 Days Ago | 0 | 0 | 7.11 | 7.93 |
| 90 Days Ago | 0 | 0 | 7.27 | 8.1 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 3 | 3 |
| Up Last 30 Days | -- | -- | 4 | 5 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | 4 | 4 |
Growth Estimates
| CURRENCY IN USD | EL.PA | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 6.50% |
| Next Qtr. | -- | -- | -- | 12.00% |
| Current Year | 8.10% | -- | -- | 5.30% |
| Next Year | 12.20% | -- | -- | 13.10% |
| Next 5 Years (per annum) | 12.10% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 18.37% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
No Fair Value available for this ticker
Related Tickers
AFX.DE Carl Zeiss Meditec AG
100.70
+0.40%
COLO-B.CO Coloplast A/S
859.00
-0.51%
ALC.SW Alcon Inc.
72.40
+0.56%
CTEC.L ConvaTec Group PLC
255.80
-0.78%
BIOT.ST Biotage AB (publ)
165.10
-0.24%
DIM.PA Sartorius Stedim Biotech S.A.
210.30
+0.96%
STMN.SW Straumann Holding AG
139.35
+0.91%
ALC Alcon Inc.
78.77
-0.09%
ALIF-B.ST AddLife AB (publ)
99.75
+1.12%
GXI.DE Gerresheimer AG
100.60
+0.10%